Verona Pharma plc announces 12 abstracts, including a mini symposium, and a clinical trials symposium, on additional analyses from its successful Phase 3 ENHANCE studies with ensifentrine for the treatment of chronic obstructive pulmonary disease have been accepted by the American Thoracic Society International Conference 2023.
OKYO Pharma Limited is pleased to announce that the first patient has been screened for its phase 2, multi-center, randomized, double–blinded, placebo-controlled trial, evaluating the efficacy and safety of OK-101 ophthalmic solution in subjects with dry eye disease.
argenx announced that members of management will participate in a fireside chat at the BofA Securities 2023 Health Care Conference on Tuesday, May 9, 2023, at 8:00 a.m. P.T. in Las Vegas, NV.
argenx to Present at BofA Securities 2023 Health Care Conference Read More »
Medigene AG reports it has partnered with Helmholtz Munich to acquire the exclusive, worldwide rights to the CD40L-CD28 costimulatory switch receptor adding to the portfolio of technologies within Medigene’s end-to-end platform.
Biophytis SA announces the strengthening of its management team with the appointment of Chiara Baccelli to the newly created position of Director of Pharmaceutical Operations and Quality Assurance and the upcoming arrival of Nicolas Fellmann as Chief Financial Officer as of 22 May 2022.
Curasight A/S announced that it has entered into an exclusive global license and collaboration agreement with Curium Inc. – a global leader in radiopharmaceuticals – for the development and commercialization of uTRACE® for use in prostate cancer.
Curasight and Curium announce global partnership for uTRACE® in prostate cancer Read More »
La American Heart Association califica qué tan cerca se alinean varios patrones de alimentación populares con la guía para una alimentación saludable para el corazón.
Medtronic received FDA approval for the first leadless pacemaker in 2016, but faces a new competitor in Abbott, which got the nod for its own leadless device last year.
Medtronic ramps up competition for leadless pacemakers with newly approved devices Read More »
The tech giant is exiting the wearables sector as it eliminates 27,000 jobs this year. Amazon’s Halo devices will stop working on Aug. 1.
Amazon closes Halo health tracking unit as wave of tech layoffs continues Read More »
The move, if completed, would mean the end of the company as a health insurer.
Bright Health explores sale of California MA business Read More »
